ASX 100

Michael O'Neill from IML and Ben Clark from TMS Private Wealth run the ruler over your most-tipped income stocks for 2025

Despite sky-high valuations, Jun Bei Liu is bullish on Pro Medicus. She first bought at $25 - now it’s 10x’d. How much higher can it climb?

This earnings season could be make-or-break for ASX resources stocks as lower commodity prices and the looming trade war come into focus.

What the market is missing on Telstra

Earnings may have bottomed out and there's hope in the air this reporting season, according to FNArena's Rudi Filapek-Vandyck

CBA's first-half result continues to showcase the same narrative – consistent earnings and dividends at a very, very expensive price tag.

David Berthon-Jones and Garry Laurence said to look for dividends or growth elsewhere as CBA is the world's most expensive bank stock.

Plasma is still a winner for the healthcare giant, but vaccinations face hurdles.

These 10 stocks will take short sellers the most days to cover positions and are most likely to sink or surge on earnings this month.

February earnings season is here, and it could be make or break for beaten down stocks in the ASX Energy sector like Woodside and Santos.

Bears can beat the bulls with growth and yield

Read on to find the ratings, consensus price targets, and FNArena insights on each stock covered.

Mr Hogan labelled inflation "the biggest strategic threat to the economy" and said the RBA has insufficient evidence it's contained.

We spoke with Brandywine Global to find out where they're seeing value around the world and why they own global airlines.

Copper’s strong run in face of trade wars piques investor interest in stocks such as Develop, discovery runaway AusQuest, Coda and Noronex.

First Sentier's David Wilson and Elston's Joe McCarthy pick apart companies with strong sales growth - is it all it's cracked up to be?

How should investors interpret Trump’s tariff threats—literally, seriously, neither, or both?

Corporate Australia has battled (too) many headwinds over the past three years, but investor optimism is on the rise for better times ahead.

BNPL has its roots in the 19th century, originating from instalment plans that allowed consumers to purchase expensive items like furniture and farm equipment by...

ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also strategically positioned to capitalise on future...

ASX-listed Brazilian Rare Earths is widely considered a potential takeover target as fund manager Regal builds a position on the register.

Elston's Joe McCarthy and First Sentier's David Wilson share their tips for hunting great growth stocks, and an example for good measure

Amid the DeepSeek-induced selloff, REITs were amongst the better performing sectors. But what will the developments mean for data centres?

Could this Australian-American healthcare stalwart hit $60/share?